Ipilimumab retreatment in patients with pretreated advanced melanoma: the expanded access programme in Italy

BACKGROUND: Retreatment with ipilimumab has been shown to re-establish disease control in some patients with disease progression. Here, we report the efficacy and safety of retreatment with ipilimumab 3 mg kg(−1) among patients participating in an expanded access programme in Italy. METHODS: Patient...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Chiarion-Sileni, V, Pigozzo, J, Ascierto, P A, Simeone, E, Maio, M, Calabrò, L, Marchetti, P, De Galitiis, F, Testori, A, Ferrucci, P F, Queirolo, P, Spagnolo, F, Quaglino, P, Carnevale Schianca, F, Mandalà, M, Di Guardo, L, Del Vecchio, M
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2014
Aiheet:
Clinical Study
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3974075/
https://ncbi.nlm.nih.gov/pubmed/24619072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.126
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia